Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?

Viruses - 1 Jun 2021

Solitano Virginia, Plaz Torres Maria Corina, Pugliese Nicola, Aghemo Alessio

Abstract excerpt

Direct-acting antivirals (DAA) have revolutionized the treatment of patients with chronic hepatitis C virus (HCV) infection, possibly leading to HCV elimination by 2030 as endorsed by the World Health Organization (WHO). However, some patients belonging to the so-called unique or special populations are referred to as difficult-to-treat due to unreached sustained virological response, potential drug side effects...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Coinfection
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Hepatitis C, Chronic

Share to HIV Infections

Share to Treatment Failure

Source

Open in PubMed Open full text

Identifiers

PMID: 34205966
DOI: 10.3390/v13061048
PMCID: PMC8228389

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?PMID 34205966Read ↗

Management of chronic hepatitis C in 2017.Semantic proximity Read ↗

[Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 1].Semantic proximity Read ↗

New hepatitis C therapies: the toolbox, strategies, and challenges.Semantic proximity Read ↗

Key points for the management of hepatitis C in the era of pan-genotypic direct-acting antiviral therapySemantic proximity Read ↗

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL.Semantic proximity Read ↗

Worldwide prevalence, genotype distribution and management of hepatitis C.Semantic proximity Read ↗

Hepatitis C-A clinical review.Semantic proximity Read ↗

An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver.Semantic proximity Read ↗

Hepatitis C: clinical management and debated issues.Semantic proximity Read ↗

The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver.Semantic proximity Read ↗

[Hepatitis C: epidemiology, management and treatment].Semantic proximity Read ↗

Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.